When was Sinemet approved by the FDA?

The U.S. Food and Drug Administration approved Sinemet in 1975 for the treatment of people with Parkinson’s disease, to ease symptoms of the neurodegenerative disorder. This marked the first approval in the U.S. of a combination therapy containing both levodopa and carbidopa. The regulatory agency also approved the medication for certain kinds of parkinsonism, or conditions with Parkinson’s-like symptoms.